Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Nayera, Hamdy"'
Autor:
Samah Fathy Semary, Mahmoud Hammad, Sonya Soliman, Nayera Hamdy, Sherine Salem, Iman zaky, Naglaa elkinaai, Nermeen Ezzat, Doaa Albeltagy, Youssef Madany
Publikováno v:
Beni-Suef University Journal of Basic and Applied Sciences, Vol 13, Iss 1, Pp 1-12 (2024)
Abstract Background Acute leukemia may present with extramedullary (EM) tissues. Myeloid sarcoma (MS) and leukemia cutis (LC) are considered extramedullary diseases. This study aims to evaluate the incidence, clinical characteristics, and prognostic
Externí odkaz:
https://doaj.org/article/c3d2c4fe8d7f4b9882b67d240dcf9ea6
Autor:
Mahmoud Hammad, Hanafy Hafez, Iman Sidhom, Dina Yassin, Sherine Salem, Khaled Alsheshtawi, Nayera Hamdy, Nahla Elsharkawy, Alaa Elhaddad
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionAllogeneic hematopoietic stem cell transplantation (HSCT) is widely used for high-risk acute lymphoblastic leukemia (ALL) patients in their first complete remission (CR1), and for relapsed patients in second complete remission (CR2).Patie
Externí odkaz:
https://doaj.org/article/bed709c504ff4fb5a1544eeaea691594
Publikováno v:
Leukemia Research Reports, Vol 10, Iss , Pp 20-25 (2018)
We have investigated the frequency and the effect of KIT mutations on the outcome of patients with CBF-AML. 69 patients (34 pediatrics and 35 adults) with CBF-AML were enrolled in the study. The frequency of KIT mutations was higher in adults compare
Externí odkaz:
https://doaj.org/article/be41598175c64b4eb757cf254994f3f0
Publikováno v:
Expert Review of Hematology. 15:465-471
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3928f16d52742a703cee5348a9290951
https://doi.org/10.1080/17474086.2022.2072825
https://doi.org/10.1080/17474086.2022.2072825
Autor:
Mahmoud Hammad, Khaled Alsheshtawi, Sonya Soliman, Hanafy Hafez, Walaa Hozayn, Hossam Bokhary, Amr El-Sayed, Amr Abdalla, Nayera Hamdy, Sherine Salem
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:e368-e374
Introduction Juvenile myelomonocytic leukemia (JMML) is a rare clonal myelodysplastic/myeloproliferative neoplasm of early childhood. Historically, it was difficult to diagnose clinically, as patients present with manifestations shared with other hem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0452aec519fe65689164d7970377098b
https://doi.org/10.1016/j.clml.2020.02.003
https://doi.org/10.1016/j.clml.2020.02.003
Publikováno v:
International Journal of Laboratory Hematology. 42:263-269
Introduction Acute myeloid leukemia (AML) is the most common acute leukemia in adults. There is growing evidence that microRNAs (miRNAs) provide prognostic information in AML. MiR-204 has a tumor suppressor function, and several studies have proven i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8ec78c2e0fb4e56b31d22415bc376aa
https://doi.org/10.1111/ijlh.13161
https://doi.org/10.1111/ijlh.13161
Autor:
Regina Spinnler, Nayera Hamdy, Ingrid Fae, Tamara Vayntrub, Katerina Tarassi, Marcelo Fernandez-Vina, Michael Halagan, Alexandra Tsirogianni, Bernd M. Spriewald, Medhat Askar, Maria Beatriz Rodriguez, Leah Zhrebker, Gideon Hönger, Gottfried Fischer, Karin Padros, Abeer Madbouly, Reem Ameen, Arthur Dunk, Shawna Kennedy, Ronald K. Charlton, Ghada I. Mossallam, Christian Bach, Salem Al Shemmari, Amanda Willis, Kazutoyo Osoegawa
Publikováno v:
Human Immunology. 80:897-905
Since their inception, the International HLA & Immunogenetics Workshops (IHIW) served as a collaborative platform for exchange of specimens, reference materials, experiences and best practices. In this report we present a subset of the results of hum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ebad06e4472b0c0948e351cfcc12b95
https://doi.org/10.1016/j.humimm.2019.07.298
https://doi.org/10.1016/j.humimm.2019.07.298
Autor:
Omayma Hassanain, Lama El Halaby, Dina Yassin, Sherine Salem, Alaa Elhaddad, Nayera Hamdy, Hanafy Hafez, Amr Abdalla, Mahmoud Hammad
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S327-S328
Context: Despite the apparent efficacy and favorable toxicity profile of TKIs, allogeneic HSCT remains the only curative treatment for CML, especially in younger patients, but transplant-related mortality should be considered. Objective: This study o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9684dc118cc70efee0c7cefec47c213e
https://doi.org/10.1016/s2152-2650(21)01768-7
https://doi.org/10.1016/s2152-2650(21)01768-7
Publikováno v:
Clinical laboratory. 67(1)
Background Acute lymphoblastic leukemia (ALL) is a heterogeneous disease with several underlying genetic ab-normalities. Several studies have tried to elucidate the prognostic significance of cytokine receptor-like factor 2 (CRLF2) overexpression in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77f07649808376ba69a20a128ecfe15a
https://pubmed.ncbi.nlm.nih.gov/33491417
https://pubmed.ncbi.nlm.nih.gov/33491417
Autor:
Alaa Elhaddad, Mahmoud Hammad, Hanafy Hafez, Lama Elhalaby, Dina Yassin, Nayera Hamdy, Omayma Hassanain, Amr Abdallah, Sherine Salem
Publikováno v:
Pediatric Transplantation. 24
Background/objectives Despite the apparent efficacy and favorable toxicity profile of TKIs, allogeneic SCT remains the only curative treatment for CML especially in younger patients, but TRM should be considered. We evaluated the clinical outcomes of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::723eb07264d082885d5d0262ea382e9b
https://doi.org/10.1111/petr.13664
https://doi.org/10.1111/petr.13664